Current calls, week 45, 2022
Tips from Grants Office ragarding current calls
Swedish and Nordic calls
Stipendier för högre utlandsstudier
Sixten Gemzéus stiftelse samt Gålöstiftelsen utdelar stipendier för högre utlandsstudier. Kvalificerad är den sökande som har utomordentliga personliga kvalifikationer och vars utlandsstudier beräknas tillföra Sverige kunskap av betydelse, som inte lämpligen kan inhämtas genom studier och/eller forskning inom landets gränser. Övre åldersgräns är 32 år. Stipendiesummor är upp till 300 000 SEK.
Closing date: January 16, 2023.
Stipendier för forskning med genusmedicinskt perspektiv
Insamlingsstiftelsen Kvinnor och Hälsa utlyser stipendier till kliniska forskare som är i början av sin forskarkarriär, som just ska eller just har disputerat, och som driver forskning med ett genusmedicinskt perspektiv. Forskningen kan innehålla biologiska och psyko-sociala aspekter på sjukdom och hälsa med köns- och genusaspekter av sjukdomens epidemiologi, patofysiologi, diagnostik, behandling och prognos. Stipendierna på 300 000 SEK stöder forskning i hjärt-kärlsjukdomar hos kvinnor. Stipendierna på 100 000 SEK ur fonden Till Anna Söderbergs Minne stöder forskning i endometrios och hjärt-kärlsjukdomar hos gravida kvinnor.
Closing date: November 18, 2022.
INVEST fellowships
INVEST, a flagship program project of the Academy of Finland led by the University of Turku and the Finnish Institute for Health and Welfare, aimed to increase wellbeing during childhood, youth and early adulthood and prevent psychosocial risks compromising such development, invites applications for its fellowships. Fellowship enables researchers to visit Turku and collaborate with research teams involved in INVEST. Funding covers travel to Turku, accommodation and a €500 per month top-up to the applicant’s salary for up to six months.
Closing date: November 21, 2022
Postdoctoral fellowships in Japan
SSF deltar i ett utbytesprogram med JSPS (Japan Society for the Promotion of Science) med syftet att uppmuntra unga doktorer till ett forskarutbyte med ledande japanska forskargrupper. Programmet sträcker sig från ett till två år.
Closing date: January 8, 2023
Nyskapande forskningsprojekt med hög risk
Vinnova stöder projekt inom program ”BioInnovation” som syftar till att verifiera, bekräfta eller avfärda nydanande innovativa uppslag för ett mer omfattande projekt. Stöd kan sökas av tillverkare, leverantörer och användare av biobaserade material, produkter och tjänster, inklusive universitet, högskolor, forskningsinstitut och andra relevanta aktörer. Högsta belopp att söka är 500 000 SEK för ett projekt. Projekt ska samfinansieras av medverkande företag med motsvarande summa som det sökta bidraget.
Closing date: March 5, 2023
Call for funding - SFO Stem cells and Regenerative medicine 2023-2024
The aim of the SFO Stem cells and Regenerative medicine is to support research and infrastructure within the field of stem cells and regenerative medicine.
Deadline: 9th January 2023
More information
Lennanders stiftelse för främjande av naturvetenskaplig och medicinsk forskning.
Härmed utlyses 6 stipendier à 300 000 kr vardera.
Till vid rikets samtliga universitet och högskolor yngre svensk forskare (svenskt medborgarskap krävs) som ekonomiskt stöd för självständiga naturvetenskapliga eller medicinska undersökningar och arbeten, vilka lovar vetenskapligt eller praktiskt betydelsefulla resultat. Ekonomiskt oberoende sökande bör inte komma ifråga. Stöd kan ges för undersöknings‐ samt levnadsomkostnader, i första hand till nydisputerade forskare som saknar försörjning och doktorander i slutfasen av sin utbildning. Det framgår i webbansökan vilka bilagor som ska bifogas.
Webbansökan ska vara inskickad senast onsdag 25 januari 2023, före kl. 17.00. Inga ändringar eller kompletteringar är möjliga efter denna tidpunkt.
Skriv in stipendienamnet i sökrutan. Klicka sedan på ”Visa information om stipendiet”.
Det går även att få fram stipendiet genom att klicka i rutan för ”Endast stipendier öppna för ansökan” och sedan välja Lennanders, och sedan på ”Visa information om stipendiet”.
European calls
Short deadline! Joint seed funding available for research collaboration with University College London (UCL)
The Cities Partnerships Programme Stockholm, comprising UCL and the Stockholm Trio of Karolinska Institutet, KTH Royal Institute of Technology & Stockholm University (KI, KTH & SU), announces a new round of joint research funding to continue to support collaborative research projects and to build on the existing partnerships between the three institutions. The aim of the fund is to catalyze new collaborations and in the longer term to build international teams who are well positioned to apply for external research funding.
For more information see Stockholm | UCL Global - UCL – University College London
To apply see Cities Programme Stockholm: 2022 Call for Collaborative Research Proposals (jotform.com)
With these funds, and a workshop hosted in Stockholm in late March, the Programme intends to develop collaborations in five key research areas:
•Social and/or institutional aspects of climate action e.g. inequalities, public and/or market engagement, technology and behaviour, relationship with rights, regulations, law, etc.
•Public health and mental health in climate adapting cities e.g. climate-health governance, individual/ social wellbeing, etc.
•Digitalisation of climate change and/or health in cities e.g. the role of Big Data, Metaverse, AI, etc.
•Housing e.g. affordability, supply, noise pollution, allergens in the living environments, access to green spaces, housing for young people, green gentrification, social segregation, etc.
•Urban safety and security e.g. urban crime, terrorism or warfare in the city, unsafe urban mobility, environmental and health disasters, etc
KI researchers that partner with UCL in an application are eligible to apply for co-funding from KI to fund their contribution to the project, subject to internal prioritisation.
Deadline: 23:59 Swedish time on 14th of November 2022, (the application form is on UCL’s website).
If you have any questions please contact Lotta Lundqvist, international relations office at lotta.lundqvist@ki.se
Networking support scheme – rare diseases; European Joint Programme on Rare Diseases
The European Joint Programme on Rare Diseases invites applications for its networking support scheme. This supports the organisation of workshops or conference for new research networks or existing research networks to strengthen collaboration and enable knowledge exchange.
Healthcare professionals, researchers and patient advocacy organisations from eligible countries may apply. Applications must be submitted by a principal applicant and two co-applicants from three different eligible countries.
Grants are worth up to €30,000 each.
Closing date: 01 December 2022
ACTERIA early career research prize - European Federation of Immunological Societies
The European Federation of Immunological Societies and Acting on European Research in Immunology and Allergology invite applications for their early career research prize. This recognises early career researchers in immunology and allergology.
Applicants must be members of an EFIS affiliated national society. Early career researchers must have conducted research in a European research institute in the past 10 years, and must have no more than 10 years of experience.
Two prizes, worth €30,000 each, are available. The winners have the possibility of receiving an extra €50,000 per year for three years to conduct a research project at a European institution.
Closing date: 31 December 2022
EFSD/Lilly exploring and applying new strategies in diabetes expand programme - European Association for the Study of Diabetes
The European Association for the Study of Diabetes invites applications for its EFSD/Lilly exploring and applying new strategies in diabetes expand programme. This supports diabetes research projects on potential strategies that can be implemented in Europe and rolled out in low- and middle income countries to favour the improvement of quality of care for people living with diabetes. Applications within any area of clinical diabetes research may be submitted, with an emphasis on:
•prevention of diabetes;
•diagnosis and management of all forms of diabetes mellitus;
•diagnosis, management and prevention of diabetes-related microvascular and macrovascular complications.
Non-profit institutions from Europe and associated countries may apply, either individually or as part of a group. Applications in collaboration with development assistance committee member countries will also be considered. Grants are generally worth up to €150,000 each, but larger grants may be awarded depending on funding requirements. Projects may last for one year or longer.
Closing date: 29 December 2022
Rising Star fellowship programme - European Association for the Study of Diabetes
The European Foundation for the Study of Diabetes, in collaboration with Novo Nordisk, invites applications for its rising star fellowships programme. This enables researchers in the field of diabetes to present an overview of their past and ongoing research activities during a multidisciplinary research symposium at the European Association for the Study of Diabetes annual meeting. The aim is to identify young researchers who are developing their research activities in Europe and encourage innovative research in the field of diabetes.
Applicants must be paid-up members of the EASD and have received their highest degree no more than five years for basic scientists or seven years for clinicians before 1 January in the year the fellowship is awarded. Applicants must be employed by a non-profit institution based in Europe or an associated country. Preference will be given to individuals who have consistently pursued a well-defined and innovative research line, leading to publications in high impact peer reviewed journals.
Travel expenses, hotel and registration costs for the recipients will be covered. Furthermore the award includes a research fellowship in the amount of Euro 30,000 payable to the recipient’s institution.
Closing date: 15 February 2023
US calls
Federal Funding agencies
2022 US Funding Seminars for US Federal agencies & Private Foundations
The FY 2023 US President’s Budget will support science that helps tackle many critical national challenges: from initiatives to address health disparities, fight the rising tide of addiction, and transform nutrition science. The budget will also build upon the initial investment in the new Advanced Research Projects Agency for Health (ARPA-H).
The overall request includes discretionary budget authority of $49.04 billion, of which $1.09 billion is associated with 21st Century Cures Act allocations, $83 million is for Superfund research activities, and $5.0 billion is for the new Advanced Research Project Agency for Health (ARPA-H). The NIH request total also includes $12.05 billion for Pandemic Preparedness and slightly over $141 million for special type 1 Diabetes research identified as mandatory resources, plus Program Evaluation financing of $1.27 billion.
On the other hand, the source of funding from US Foundations are also pivotal for the complementary input of the governmental funding.
From these sessions, you will receive the understanding of US research funding mechanism, new funding opportunities and current KI awardees experiences-sharing!
US Federal Agencies
- Time: 2022 November 15 (Tuesday) 12.00-13.00 by ZOOM.
- The following Prime awardees will share her tips and available for Q&A session.
- Sara Hagg (National Institutes of Health R01/Prime) - Repurposing drugs for Alzheimer´s disease using a reverse translational approach
- Sara Hagg (National Institutes of Health R01/Prime) - Repurposing drugs for Alzheimer´s disease using a reverse translational approach
- The following Prime awardees will share her tips and available for Q&A session.
-
-
- Fang Fang (Centers for Disease Control and Prevention R01/Prime) - Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden
-
US Private Foundation
- Time: 2022 November 24 (Thursday) 12.00-13.00 by ZOOM.
- The following Prime awardees will share his/her tips and available for Q&A session.
- Gefei Chen (Alzheimer's Association Research Grant (AARG) Prime) - The chaperone domain BRICHOS in prevention/treatment of Alzheimer's disease
- Gefei Chen (Alzheimer's Association Research Grant (AARG) Prime) - The chaperone domain BRICHOS in prevention/treatment of Alzheimer's disease
- The following Prime awardees will share his/her tips and available for Q&A session.
-
-
- Christer Halldin (Michael J. Fox Foundation Prime) - Development of PET tracer for imaging SV2C in Parkinson´s disease
-
More info: KI Calendar
More info about US Research Funding at KI
Please have your registration by sending an email to Christine.chang@ki.se in order to receive your ZOOM link.
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional): NIH
The National Institutes of Health (NIH) hereby notify Principal Investigators on specific types of NIH research grants, listed in the Urgent Notice of Special Interest that funds may be available for competitive revisions to meet immediate needs to help address a specific public health crisis in a timely manner, but that were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted. Applications for Urgent Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA of the most recent parent award.
Only applications submitted in response to an Urgent Guide Notice published by an IC will be allowed to apply to this FOA.
Deadline: Earliest start dates may vary by awarding IC.
Funding Opportunity Announcement (FOA): PA-23-044
Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed): NIH
Genes or variants with addiction-relevant phenotypes that have been validated orthogonally require further characterization to identify the causal mechanisms involved. These studies usually entail the creation of conditional gene knockout or knockin animals for characterization of resultant behavioral, molecular, neurobiological, or other phenotypes. Rapidly evolving genome editing technologies can significantly decrease the time and effort it takes to generate knockout, knockdown, or knockin animals and can even be applied to species that have previously been more challenging to manipulate genetically (e.g. rat, primate). The purpose of this initiative is to support projects that functionally validate and/or characterize genes or variants involved in substance use disorder-relevant phenotypes.
Deadline: March 02, 2023, July 26, 2023, March 04, 2024, July 26, 2024, March 03, 2025, July 28, 2025. Applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-23-041
Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed): NIH
The goal of this Funding Opportunity Announcement (FOA) is to encourage research to explore mechanisms of inflammasome activation, humoral immune reaction and potential antibody-mediated enhancement, and their link to immune functions in people with HIV and substance use disorders (SUDs). This FOA supports studies to either (1) elucidate the mechanisms of inflammasomes in virus and drug-induced immune activation, or (2) identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among individuals with SUD. Success of these projects may lead to development of novel therapies that target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation in people with HIV.
Deadline: March 16, 2023 (R01); March 15, 2023 (R21). Applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-DA-24-003 (R01); RFA-DA-24-004 (R21).
More information: (R01); (R21).
HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain (RM1 Clinical Trial Optional): NIH
This funding opportunity announcement (FOA) is designed to support integrated efforts of three or more (up to six) PDs/PIs to pursue bold, impactful, and challenging research in basic and clinical pain domains to understand the biology of specific human pain conditions as well as pain associated with various diseases/disorders, including mechanistic underpinning of heterogeneity and stratification of patients with specific pain conditions and co-morbidities. The research approach should be interdisciplinary in nature, and the research teams are expected to establish a common goal that requires collaboration, synergy, and managed team interactions. Proposed research should not represent a collection of individual efforts or parallel projects. Proposed research should support a cohesive, single, well-integrated research plan with a singular focus, one set of aims, and a budget without subprojects. Teams must leverage appropriate multi-disciplinary expertise to develop new principles and methods for experimentation, analysis, and interpretation. Teams are encouraged to consider transformative objectives with defined 5-year outcomes that will produce major advances in the understanding of human pain conditions and are likely to improve strategies for effective management of human pain.
Deadline: February 14, 2023; June 14, 2023; October 13, 2023; February 12, 2024. Applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-22-069.
Foundations
Clinic and laboratory integration programme grants, Cancer Research Institute, US
The Cancer Research Institute established Clinic and Laboratory Integration Program to support investigators who are studying critical topics at the intersection of laboratory and clinical research in immuno-oncology. CLIP grants provide up to $200,000 over a two-year period.
Proposals in all cancers are encouraged.
Deadline: December 1st, 2022 (LOI), March 1, 2023 (Full proposal).
PSF/MTF Biologics allograft tissue research grant, Plastic Surgery Foundation (PSF) and the Musculoskeletal Transplant Foundation (MTF), US
The PSF and MTF Biologics offer research grants to investigators studying allograft tissue transplantation in plastic and reconstructive surgery. These grants are intended to provide support for research projects focused on biologic repair and reconstruction with a strong clinical translation component that utilize dermal, adipose, placental or other allograft transplant technologies. Proposed studies should focus on novel translational and clinical research in the fields of tissue allograft transplantation and science, novel uses of allografts, combination with other biomaterials to enhance properties and transformative regenerative medicine technologies relying on allograft tissues and matrices. The grant is up to $75,000 for projects up to 2 years.
Deadline: December 1, 2022.
Conference Awards, Parkinson’s Foundation, US
Conference Awards support the gathering of experts in the field working to address unsolved clinical or basic science problems relevant to Parkinson's disease. Maximum of $15,000 per award.
Deadline: open year-round. Applicants must submit the application at least 90 days prior to the proposed conference start date.
Research scholar programme, Google, US
Google invites applications for its research scholar programme. This supports early-career professors who are pursuing research in fields relevant to Google. Eligible fields are:
algorithms and optimisation; applied science; geography and maps; health research; human-computer interaction; machine learning and data mining; machine perception; mobile; natural language processing; networking; privacy; quantum computing; security; software engineering and programming languages; structured data, extraction, semantic graph and database management; systems, including hardware and software.
Applicants must be a full-time assistant, associate, or professor at a university or degree-granting research institution worldwide and be within seven years of completing their PhD at the time of the application submission. Post doctoral staff may serve as a co-PI. Candidates can apply a maximum of three times.
Funding is worth up to USD 60,000 for one year.
Deadline: December 1, 2022. Notification of decisions will be announced by email in April 2023.
More information
Research grants, Cystic Fibrosis Foundation, US
The Cystic Fibrosis Foundation invites applications for its research grants. These encourage the development of new information that contributes to the understanding of the basic aetiology and pathogenesis of cystic fibrosis. Studies must focus on basic science research. The PI must be independent investigators.
Awards are worth up to USD 150,000 per year for up to two years, with the possibility of renewal.
Deadline: December 8, 2022